Development, validation, user testing of patient information leaflet to improve awareness of metabolic side effects in patients on atypical antipsychotics

• Príomhchruthaitheoirí: Pooja Gopal Poojari (Údar), Keshava Pai (Údar), Sohil A. Khan (Údar), Sonia Shenoy (Údar), P.V. Bhandary (Údar), Sahana Shetty (Údar), Leelavathi D. Acharya (Údar), Swarnali Bose (Údar), Girish Thunga (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Elsevier, 2024-09-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: Metabolic adverse effects of second-generation antipsychotics (SGAs) have been well-documented in literature. This study aimed to develop, validate, and evaluate the usefulness of patient information leaflet (PIL) by user testing method to improve metabolic monitoring for psychiatric pat...